Uso de topotecan no tratamento do tumor epitelial de ¢vario refrat¢rio … platina: experiˆncia do INCA

Ara£jo, Luiz Henrique de Lima; Vieira, Fernando Meton de Alencar Cƒmara; Small, Isabele µvila; Mora, Paulo Alexandre Ribeiro; Coura, Luciana Camillo; Adv¡ncula, Gustavo Henrique Gomes.
Rev. bras. cancerol ; 54(2): 131-138, 2008.
Artículo en Portugués | TXTC | ID: txt-25116

Documentos relacionados

  1. O significado da a‡Æo educativa consulta de enfermagem no ambulat¢rio de quimioterapia infantil: perspectiva dos familiares
  2. Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition.
  3. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.
  4. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma].
  5. Differential dynamics and direct interaction of bound ligands with lipids in multidrug transporter ABCG2.
  6. Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy.
  7. Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation.
  8. A sensitive bioanalytical ultra-high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous quantitation of lactone and carboxylate forms of topotecan in plasma and vitreous.
  9. Self-assembled ordered AuNRs-modified electrodes for simultaneous determination of dopamine and topotecan with improved data reproducibility.
  10. Treatment of platinum refractory or resistant ovarian cancer.